encenicline (EVP-6124) - Forum Pharmaceuticals, Mitsubishi Tanabe
Forum Pharmaceuticals: Regulatory Update (Forum Pharmaceuticals) - Nov 27, 2015 - Anticipated top-line data from P3 trials (NCT01714661, NCT01716975) for cognitive impairment in schizophrenia in H1 2016 
Anticipated P3 data: top line • Schizophrenia
http://www.forumpharma.com/forum-pharmaceuticals-inc-announces-removal-of-partial-clinical-hold-on-phase-3-encenicline-program-for-cognitive-impairment-in-schizophrenia/
 
Nov 27, 2015